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Introduction
Congenital neutropenias (CN) constitute a group of rare
genetic disorders characterized by: severe recurrent
infections secondary to neutropenia, various organic
dysfunctions and a high risk of leukemic transformation.
Their incidence is estimated to be 1-4 cases per 1 million
inhabitants. .
Objective of the study
Clinical Features
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Classification of CN according to the severity of neutropenia
Types of neutropenia ANC variance
Mild neutropenia ANC 1000e1500/mL
Moderate neutropenia ANC 500e1000/mL
Severe neutropenia ANC <500/mL
Persistent neutropenia ANC continuously <1500/mL
Intermitent neutropenia ANC occasionally <1500/mL
Cyclic neutropenia ANC with periodic oscillations and 
nadir <1000
Patients with CN develop severe bacterial infections in the first year 
of life. The risk of infection correlates with the degree( tab.1) and 
duration of neutropenia. The most frequently affected sites of 
infections are skin and mucosal linings in the oropharynx with 
bronchial and lung infections also common. Patients with CN are at 
risk for fatal sepsis, a feature that must be remembered.
Diagnosis Conclusion
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The diagnosis of CN relies on clinical and hematological features. Before 
the diagnosis of congenital neutropenia can be established, it is important to 
document the duration of neutropenia and whether it is persistent versus 
intermittent by serial complete blood counts. A single documentation of a 
low neutrophil count is not sufficient. To monitor the oscillatory pattern of 
neutrophil counts in patients with cyclic neutropenia, 2-3 blood counts per 
week for six weeks are needed. Patients with CN often have increased 
absolute numbers of monocytes and B cells, accompanied by 
hypergammaglobulinemia.
Morphological assessment of stained peripheral blood neutrophils and bone 
marrow progenitor cells are helpful to clarify the etiology of CN(fig.1)
The genetic confirmation of the diagnosis is mandatory. 
Figure 1. Tipical aspect of the bone marrow in a CN patient:The bone marrow 
usually shows a maturation arrest of neutrophil precursors at an early stage 
(promyelocyte/myelocyte level) with few cells of the neutrophilic series beyond the
promyelocyte stage (x100) 
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This review aims to provide a comprehensive overview of the
latest literature sources on the clinical and diagnostic features of
congenital neutropenias.
Were studied the articles published in the last 10 years,




CN are rare genetic diseases characterized by an absolute
number of neutrophils less than 1.5x109 /l that are associated
with specific clinical phenotypes (pyogenic infections, gingivo-
stomatitis, chronic periodontitis, etc.)
In 1956 the Swedish physician Rolf Kostmann described an
autosomal recessive hematologic disorder with severe
neutropenia with an absolute neutrophil count (ANC) less than
0.2x109/L and early onset of severe bacterial infections. And from
that point the history of CN has starts





• GI inflammation mimicking inflammatory bowel
• Lack or diminished inflammatory infiltrates and pus in response 
to bacterial infections.
• A predisposition to bone fractures secondary to osteopenia
• inner ear hearing loss(in G6PC3 deficiency or GFI1 deficiency)
• epilepsy and delayed neurocognitive development (in HAX1 
deficiency or CLPB-deficiency
Table 1. Classification of CN according to clinico-hematological aspects
of neutropenia
Two turning points revolutionized the scientific community studying CN:
1. Approval for the use of granulocyte colony-stimulating factor(G-CSF) –
filgrastim - 1993
2. 2. Large-scale implementation of molecular-genetic techniques for CN 
diagnosis as RT-PCR; FISH; NGS sequencing etc (2000s)
Currently, mutations in more than 20 genes have been implicated as the 
cause of SCN.∗1 These mutations affect
the function of a variety of proteins that exert widely diverse
intracellular functions, among which protein trafficking, actin
cytoskeleton organization, mitochondrial integrity, transcriptional control and 
signal transduction.(tab. 2)
Disorder Genetic Defect Recessive CN Dominant CN
Clinical Presentation:
Neutropenia plus
Congenital neutropenia with ELA 2
mutations
ELA2 - + Preleukemic syndrome / MDS
Congenital neutropenia with GFI-1
mutation
GFI-1 - + B-/T-cell deficiency
WHIM syndrome CXCR4 - + Myelokathexis, IgG deficiency, warts
Shwachman-Diamond syndrome SBDS + - Exocrine pancreas insufficiency
Glycogen storage disease, type Ib
Glucose-6-phosphate-
Translocase
+ - Hypoglycemia, lactic acidosis
Hyper IgM CD40-L X-linked - IgG, IgA, IgE deficiency
Barth syndrome (3-methylglutaconic
aciduria)
Taz 1 X-linked -
Dilatative cardiomyopathy, skeletal
myopathy, short stature
Congenital neutropenia with WASP
mutation
WASP X-linked - Monocytopenia, platelets normal
Hermansky-Pudlak syndrome AP3B1 + -
Partial albinism, short stature, IgG
deficiency, platelet dysfunction




Partial albinism, short stature, IgG
deficiency
Griscelli syndrome Rab27a + - Partial albinism, hemophagocytosis
Chediak-Higashi syndrome LYST (CHS1) + - Partial albinism, T-/natural killer
Congenital neutropenia
(unclassified)
Not known + ? Elevated IgG levels
Table 2. Moleccular Clasification of  Congenital Neutropenias
Knowledge of the genetic defects of CN has valuable implications not 
only in the classification of these nosological entities, but can also serve 
as a target for potential molecular therapies in the near future.
